Using ultrasound and blood tests to predict varices risk in cirrhosis
Part of Digestive system clinical trials.
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of cirrhosis (based on medical history, physical exam, lab tests, imaging, or liver biopsy).
- You must have had an upper endoscopy (gastroscopy) recently.
- You must not have had a past variceal bleed, TIPS procedure, or endoscopic treatment for varices.
- You must not have active liver cancer, a portal vein clot, or a removed spleen.
- You must not have used medications that affect platelets, liver function, or blood clotting in the past week, nor received a blood transfusion recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special blood pressure measurement in the liver (called HVPG) can help doctors choose the best endoscopic treatment for people with cirrhosis who have had variceal bleeding. If you've had bleeding from varices, this study aims to make your follow-up care more personalized and effective.
This study compares two ways to prevent future bleeding from enlarged veins in the esophagus or stomach in people with liver cirrhosis. One method uses a small tube (called TIPS) to reduce pressure in the liver, and the other combines a banding procedure with medication. The goal is to see which approach works better.
This study uses ultrasound (sound wave imaging) to check your liver and veins to see if you are at risk for bleeding from enlarged veins in your food pipe. It may help find a safer, less invasive way to predict bleeding risk compared to routine endoscopy.
This study tests whether treating enlarged veins in the food pipe or stomach (called varices) in a day-care unit, without an overnight hospital stay, is safe and feasible for people with cirrhosis. The treatment aims to prevent these veins from bleeding.
This trial tests a slightly smaller TIPS stent (underdilated) against the standard size to see which is better at preventing another variceal bleed in people with cirrhosis and liver scarring. It aims to find the safest way to lower pressure in the veins while reducing side effects.
This study tests a new way to treat bleeding varicose veins in the stomach by using endoscopic ultrasound to guide the procedure, for people with liver cirrhosis. It aims to improve how this bleeding is managed.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.